Skip to main content
. 2020 Jul 28;20:698. doi: 10.1186/s12885-020-07199-0

Table 3.

Clinical effectiveness

Characteristics Data
ORR 41.20%
DCR 70.60%
M-PFS (months) 6 (95%CI: 2–9)
6 months PFS rate 64.71%

Data are presented as percentages or means

Abbreviations: ORR The objective response rate, DCR The disease control rate, m-PFS The median progression-free survival